출판 : MarketsandMarkets（마켓츠앤마켓츠）출판년월 : 2022년07월
3D 바이오프린팅(3D Bioprinting) 시장 : 컴포넌트[3D 바이오프린터(마이크로 익스루젼, 잉크젯, 레이저, 자기), 바이오잉크(천연, 합성, 하이브리드)], 재료(히드로겔, 생세포), 용도(연구, 임상), 최종 사용자(바이오파마, 아카데미아) – 2027년까지의 세계 예측
3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material(Hydrogel, Living Cells), Application (Research, Clinical), End user (Biopharma, Academia) – Global Forecast to 2027
| 페이지수 | 259 |
| 도표수 | 335 |
| 구성 | 영문조사보고서 |
| 가격 |
The global 3D Bioprinting market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 3.3 billion by 2027, at a CAGR of 20.8% during the forecast period. Factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities drive the market growth.
전 세계 3D 바이오프린팅 시장의 가치는 2022년에 13억 달러로 추산되며 예측 기간 동안 CAGR 20.8%로 2027년까지 33억 달러에 이를 것으로 예상됩니다. 3D 바이오 프린터 및 바이오 재료의 기술 발전, 제약 및 미용 산업에서의 3D 바이오 프린팅 사용 증가, 바이오 프린팅 연구 활동을 지원하기 위한 공공 및 민간 자금 증가와 같은 요인이 시장 성장을 주도합니다.
However,factors likedearth of skilled professionals and high development and production costs are restraining the growth of this market.
“The 3D Bioprinterssegmentaccounted for the highest growth rate in the 3D Bioprintingmarket, bycomponent, during the forecast period”
In 2021, the 3D Bioprinters segment accounted for the highest growth rate. In biological sciences and the bioengineering field, 3D bioprinters help in printing living cells layer-by-layer. The idea of printing entire organs—such as the liver, teeth, heart, ears, and lungs—grown from samples of an individual’s body tissue is in process and gaining tremendous attention worldwide and thus, favoring growth of this market.
“Asia Pacific: The fastest-growing regionin the3D Bioprintingmarket”
The Asia Pacific market is estimated to record the highest CAGR during the forecast period. The high growth rate of this market can beattributed to theincreasing research activities, growing demand for organ transplants, increasing number of initiatives by market players for expanding their presence in the APAC, and the higher adoption of stem cell research in several Asian countries.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80%and Demand Side 20%
• By Designation: C-level (Managers) – 45%, D-level(CXOs, Directors)- 30%, and Others (Executives) – 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• BICO Group AB (US)
• Organovo Holdings Inc. (US)
• Allevi, Inc. (part of 3D Systems, Inc.) (US)
• CollPlant Biotechnologies Ltd. (Israel)
• regenHU (Switzerland)
• EnvisionTEC GmbH (part of Desktop Metal) (Germany)
• Aspect Biosystems Ltd. (Canada)
• Advanced Solutions Life Sciences, LLC (US)
• Cyfuse Biomedical K.K. (Japan)
• ROKIT Healthcare, Inc. (South Korea)
• Regenovo Biotechnology Co., Ltd. (part of Shining 3D Tech Co., Ltd.) (China)
• Pandorum Technologies Pvt. Ltd. (India)
• Foldink Life Science Technologies (Armenia)
• Revotek Co., Ltd. (US)
• Precise Bio (US)
• Brinter (Finland)
• Prellis Biologics (US)
• Regemat 3D (Spain)
• 3DBio Therapeutics (US)
• Tissue Regeneration Systems Inc. (US)
• Poietis (France)
• SunP Biotech, LLC (US)
• Vivax Bio, LLC (US)
• GeSiM mbH (Germany)
• Manchester BIOGEL (UK).
Research Coverage:
This report provides a detailed picture of theglobal 3D Bioprinting Market. It aims at estimating the size and future growth potential of the market across different segments such as thecomponent, material, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D BioprintingMarketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, challenges, restraints,trends,and opportunities.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 37)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 42)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 3D BIOPRINTING MARKET (SUPPLY SIDE): CAGR PROJECTIONS
FIGURE 7 3D BIOPRINTING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. – 52)
FIGURE 9 3D BIOPRINTING MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
FIGURE 10 3D BIOPRINTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 3D BIOPRINTING MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION)
FIGURE 12 3D BIOPRINTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET
4 PREMIUM INSIGHTS (Page No. – 56)
4.1 3D BIOPRINTING MARKET OVERVIEW
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS IN 3D BIOPRINTING INDUSTRY TO DRIVE MARKET
4.2 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT AND COUNTRY (2021)
FIGURE 15 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN 3D BIOPRINTING MARKET IN 2021
4.3 3D BIOPRINTING MARKET SHARE, BY MATERIAL, 2022 VS. 2027
FIGURE 16 LIVING CELLS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
4.4 3D BIOPRINTING MARKET SHARE, BY END USER, 2022
FIGURE 17 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE LARGEST END USERS OF 3D BIOPRINTING MARKET
4.5 3D BIOPRINTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH FROM 2022 TO 2027
5 MARKET OVERVIEW (Page No. – 59)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing use of 3D bioprinting in pharmaceutical and cosmetology industries
5.2.1.2 Developments in 3D bioprinting for tissue and organ regeneration applications
5.2.1.3 Rising public and private funding to support bioprinting research activities
5.2.1.4 Technological advancements in 3D bioprinting industry
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled professionals
5.2.2.2 High development and production costs
5.2.2.3 Lack of regulatory guidelines governing 3D bioprinting
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for organ transplant
5.2.3.2 Growing awareness of 3D bioprinting
5.2.3.3 Growing demand for regenerative medicine and stem cell research
5.2.4 CHALLENGES
5.2.4.1 Socioethical concerns related to use of 3D-bioprinted products
5.2.4.2 High cost of 3D bioprinting
5.2.4.3 Process control and understanding of 3D bioprinters
5.3 RANGES/SCENARIOS
FIGURE 20 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF 3D BIOPRINTING MARKET
5.4 IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
FIGURE 21 3D BIOPRINTING MARKET SCENARIO PRE- AND POST-COVID-19, 2020–2022
FIGURE 22 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 PRICING ANALYSIS
5.6 TECHNOLOGY ANALYSIS
TABLE 1 COMPARISON OF BIOPRINTING TECHNIQUES
TABLE 2 ADVANTAGES AND DISADVANTAGES OF 3D BIOPRINTING TECHNIQUES
5.7 PATENT ANALYSIS
FIGURE 23 PATENT APPLICATIONS FOR 3D BIOPRINTING MARKET, JANUARY 2011–MAY 2022
TABLE 3 INDICATIVE LIST OF PATENTS IN 3D BIOPRINTING MARKET
5.8 VALUE CHAIN ANALYSIS
FIGURE 24 VALUE CHAIN ANALYSIS OF 3D BIOPRINTING MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE
5.8.1 RESEARCH & DEVELOPMENT (R&D)
5.8.2 MANUFACTURING & ASSEMBLY
5.8.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL AND MEDIUM-SIZED ENTERPRISES (SMES)
5.9.3 END USERS
FIGURE 25 3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM ANALYSIS OF 3D BIOPRINTING MARKET
TABLE 4 SUPPLY CHAIN ECOSYSTEM
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 5 3D BIOPRINTING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.12 REGULATORY ANALYSIS
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.13.1 THREAT OF NEW ENTRANTS
5.13.2 THREAT OF SUBSTITUTES
5.13.3 BARGAINING POWER OF SUPPLIERS
5.13.4 BARGAINING POWER OF BUYERS
5.13.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF 3D BIOPRINTING PRODUCTS
5.14.2 BUYING CRITERIA FOR 3D BIOPRINTING PRODUCTS
FIGURE 27 KEY BUYING CRITERIA FOR END USERS
6 3D BIOPRINTING MARKET, BY COMPONENT (Page No. – 81)
6.1 INTRODUCTION
TABLE 11 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
6.2 3D BIOPRINTERS
6.2.1 3D BIOPRINTERS MARKET, BY TECHNOLOGY
TABLE 12 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 13 3D BIOPRINTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 14 NORTH AMERICA: 3D BIOPRINTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 15 EUROPE: 3D BIOPRINTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 16 ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.1 Microextrusion bioprinting
6.2.1.1.1 Increasing research in microextrusion fueling adoption of this technology
TABLE 17 MICROEXTRUSION 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 18 NORTH AMERICA: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 19 EUROPE: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 20 ASIA PACIFIC: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2 Inkjet 3D bioprinting
6.2.1.2.1 High cell viability and low cost resulted in increased demand for inkjet 3D bioprinting
TABLE 21 INKJET 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 22 NORTH AMERICA: INKJET 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 23 EUROPE: INKJET 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 24 ASIA PACIFIC: INKJET 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.3 Laser-assisted bioprinting
6.2.1.3.1 Laser-assisted bioprinting among highest-resolution bioprinting technologies available in 3D bioprinting industry
TABLE 25 LASER-ASSISTED 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 26 NORTH AMERICA: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 27 EUROPE: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 ASIA PACIFIC: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.4 Stereolithography-based bioprinting
6.2.1.4.1 Stereolithography offers high printing quality, speed, and cell viability
TABLE 29 STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 30 NORTH AMERICA: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 31 EUROPE: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 32 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.5 Magnetic 3D bioprinting
6.2.1.5.1 Accuracy and speed are major advantages of magnetic 3D bioprinting
TABLE 33 MAGNETIC 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 34 NORTH AMERICA: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 EUROPE: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 36 ASIA PACIFIC: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.6 Other technologies
TABLE 37 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 38 NORTH AMERICA: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 39 EUROPE: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 40 ASIA PACIFIC: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 BIOINKS
TABLE 41 BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 44 EUROPE: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 ASIA PACIFIC: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1 NATURAL BIOINKS
6.3.1.1 Natural bioinks most preferred bioink in 3D bioprinting process
TABLE 46 NATURAL BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 48 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 49 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 HYBRID BIOINKS
6.3.2.1 Hybrid bioinks possess high mechanical strength and biocompatibility
TABLE 50 HYBRID BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 52 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3 SYNTHETIC BIOINKS
6.3.3.1 Improved mechanical strength and consistency offered by synthetic bioinks to drive market
TABLE 54 SYNTHETIC BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 55 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 56 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 57 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 3D BIOPRINTING MARKET, BY MATERIAL (Page No. – 106)
7.1 INTRODUCTION
TABLE 58 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
7.2 LIVING CELLS
7.2.1 ETHICAL ISSUES ASSOCIATED WITH USE OF LIVING CELLS IN ORGAN DEVELOPMENT TO HAMPER MARKET GROWTH
TABLE 59 3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION, 2020–2027 (USD MILLION)
TABLE 60 NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 HYDROGELS
7.3.1 DYNAMIC PROPERTIES OF HYDROGELS SUPPORT THEIR ADOPTION IN 3D TISSUE ENGINEERING
TABLE 63 3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION, 2020–2027 (USD MILLION)
TABLE 64 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 66 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 EXTRACELLULAR MATRICES
7.4.1 ECM HAS EMERGED AS PROMISING TOOL IN TISSUE ENGINEERING
TABLE 67 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 69 EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 70 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 OTHER BIOMATERIALS
TABLE 71 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS, BY REGION, 2020–2027 (USD MILLION)
TABLE 72 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 73 EUROPE: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 74 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS, BY COUNTRY, 2020–2027 (USD MILLION)
8 3D BIOPRINTING MARKET, BY APPLICATION (Page No. – 118)
8.1 INTRODUCTION
TABLE 75 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 RESEARCH APPLICATIONS
TABLE 76 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 78 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 79 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1 DRUG RESEARCH
8.2.1.1 Drug research is largest and fastest-growing segment of 3D bioprinting market
TABLE 81 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY REGION, 2020–2027 (USD MILLION)
TABLE 82 NORTH AMERICA: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 84 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 REGENERATIVE MEDICINE
8.2.2.1 Growing demand for organ transplant to support market growth
TABLE 85 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2020–2027 (USD MILLION)
TABLE 86 NORTH AMERICA: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 87 EUROPE: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 88 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.3 3D CELL CULTURE
8.2.3.1 Rising focus on developing alternatives to animal testing to drive market for 3D cell culture
TABLE 89 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY REGION, 2020–2027 (USD MILLION)
TABLE 90 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 92 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CLINICAL APPLICATIONS
TABLE 93 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 95 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 96 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 97 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.1 SKIN
8.3.1.1 Growing number of aesthetic and reconstruction surgeries to propel market growth
TABLE 98 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 99 NORTH AMERICA: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 100 EUROPE: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 101 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.2 BONE AND CARTILAGE
8.3.2.1 Increasing incidence of musculoskeletal conditions to drive demand for bone grafts
TABLE 102 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 103 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 104 EUROPE: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 105 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.3 BLOOD VESSELS
8.3.3.1 Increasing research activities focused on 3D bioprinting of blood vessels major factor driving market
TABLE 106 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 107 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 108 EUROPE: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 109 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.4 OTHER CLINICAL APPLICATIONS
TABLE 110 LIST OF ONGOING CLINICAL TRIALS
TABLE 111 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 112 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 113 EUROPE: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 114 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9 3D BIOPRINTING MARKET, BY END USER (Page No. – 142)
9.1 INTRODUCTION
TABLE 115 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
9.2.1 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE FASTEST-GROWING END USERS OF 3D BIOPRINTING MARKET
TABLE 116 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
TABLE 117 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 118 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 119 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 BIOPHARMACEUTICAL COMPANIES
9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE ADOPTION OF 3D BIOPRINTING
TABLE 120 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 121 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 122 EUROPE: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 123 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 HOSPITALS
9.4.1 3D PRINTING OFFERS A CUSTOMIZED SURGICAL PLANNING TOOL FOR HOSPITALS
TABLE 124 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
TABLE 125 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 126 EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 127 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
10 3D BIOPRINTING MARKET, BY REGION (Page No. – 151)
10.1 INTRODUCTION
TABLE 128 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
TABLE 129 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 130 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 131 NORTH AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 132 NORTH AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 134 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 135 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US dominates global 3D bioprinting market
TABLE 138 US: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 139 US: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 140 US: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 US: 3D BIOINKS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 142 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 143 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 US: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Government initiatives to support growth of 3D bioprinting market in Canada
TABLE 146 CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 147 CANADA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 148 CANADA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 150 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 151 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 154 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 155 EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 156 EUROPE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 157 EUROPE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 159 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 160 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Increasing demand for organ transplant to drive market
TABLE 163 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 164 GERMANY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 165 GERMANY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 167 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 168 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Increased funding and grants to support research activities related to 3D bioprinting in UK
TABLE 171 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 172 UK: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 173 UK: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 175 UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 176 UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 UK: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Rising adoption of 3D bioprinting technology to propel market growth
TABLE 179 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 180 FRANCE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 181 FRANCE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 183 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 184 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Italy is leading life science research hub in Europe
TABLE 187 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 188 ITALY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 189 ITALY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 191 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 192 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing funding from private and public organizations to aid market growth in Spain
TABLE 195 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 196 SPAIN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 197 SPAIN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 199 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 200 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 203 ROE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 204 ROE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 205 ROE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 ROE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 207 ROE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 208 ROE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 209 ROE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 210 ROE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT
TABLE 211 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 212 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 213 ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 214 ASIA PACIFIC: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 216 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 217 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Market in China projected to register significant growth owing to rising regenerative medicine research
TABLE 220 CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 221 CHINA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 222 CHINA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 223 CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 224 CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 225 CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 226 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 227 CHINA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Strong research base and government support to drive market for 3D bioprinting in Japan
TABLE 228 JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 229 JAPAN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 230 JAPAN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 231 JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 232 JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 233 JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 234 JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 235 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Initiatives to raise awareness and develop novel products to support market growth
TABLE 236 INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 237 INDIA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 238 INDIA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 239 INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 240 INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 241 INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 242 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 243 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Increased awareness about 3D bioprinting to drive market in South Korea
TABLE 244 SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 245 SOUTH KOREA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 246 SOUTH KOREA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 247 SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 248 SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 249 SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 250 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 251 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 252 ROAPAC: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 253 ROAPAC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 254 ROAPAC: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 255 ROAPAC: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 256 ROAPAC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 257 ROAPAC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 258 ROAPAC: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 259 ROAPAC: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 GROWING MEDICAL TOURISM TO DRIVE MARKET FOR 3D BIOPRINTING IN LATIN AMERICA
TABLE 260 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 261 LATIN AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 262 LATIN AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 263 LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 264 LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 265 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 266 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 267 LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST AND AFRICA
10.6.1 GROWING RESEARCH EFFORTS TO BOOST MARKET GROWTH
TABLE 268 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 269 MIDDLE EAST AND AFRICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 270 MIDDLE EAST AND AFRICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 271 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 272 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 273 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 274 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 275 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. – 215)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 30 KEY DEVELOPMENTS IN 3D BIOPRINTING MARKET, 2019–2022
11.3 MARKET SHARE ANALYSIS
FIGURE 31 3D BIOPRINTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
TABLE 276 3D BIOPRINTING MARKET: DEGREE OF COMPETITION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 32 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN 3D BIOPRINTING MARKET, 2019–2021
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 33 3D BIOPRINTING MARKET: COMPANY EVALUATION QUADRANT, 2021
11.6 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 34 3D BIOPRINTING MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
11.7 COMPANY FOOTPRINT ANALYSIS
11.7.1 PRODUCT FOOTPRINT OF COMPANIES
TABLE 277 PRODUCT FOOTPRINT OF COMPANIES IN 3D BIOPRINTING MARKET (2021)
11.7.2 REGIONAL FOOTPRINT OF COMPANIES
TABLE 278 REGIONAL FOOTPRINT OF COMPANIES IN 3D BIOPRINTING MARKET (2021)
11.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
TABLE 279 3D BIOPRINTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
11.9 COMPETITIVE SCENARIO
TABLE 280 KEY PRODUCT LAUNCHES
TABLE 281 KEY DEALS
TABLE 282 OTHER KEY DEVELOPMENTS
12 COMPANY PROFILES (Page No. – 226)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats)*
12.1.1 BICO GROUP AB
TABLE 283 BICO GROUP AB: BUSINESS OVERVIEW
FIGURE 35 BICO GROUP AB: COMPANY SNAPSHOT (2021)
12.1.2 ORGANOVO HOLDINGS INC.
TABLE 284 ORGANOVO HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 36 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2020)
12.1.3 ALLEVI, INC. (PART OF 3D SYSTEMS, INC.)
TABLE 285 3D SYSTEMS, INC.: BUSINESS OVERVIEW
FIGURE 37 3D SYSTEMS, INC.: COMPANY SNAPSHOT (2021)
12.1.4 COLLPLANT BIOTECHNOLOGIES LTD.
TABLE 286 COLLPLANT BIOTECHNOLOGIES LTD.: BUSINESS OVERVIEW
FIGURE 38 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2021)
12.1.5 REGENHU
TABLE 287 REGENHU: BUSINESS OVERVIEW
12.1.6 ENVISIONTEC GMBH (PART OF DESKTOP METAL, INC.)
TABLE 288 ENVISIONTEC GMBH: BUSINESS OVERVIEW
12.1.7 ASPECT BIOSYSTEMS LTD.
TABLE 289 ASPECT BIOSYSTEMS LTD.: BUSINESS OVERVIEW
12.1.8 ADVANCED SOLUTIONS LIFE SCIENCES, LLC
TABLE 290 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: BUSINESS OVERVIEW
12.1.9 CYFUSE BIOMEDICAL K.K.
TABLE 291 CYFUSE BIOMEDICAL K.K.: BUSINESS OVERVIEW
12.1.10 ROKIT HEALTHCARE, INC.
TABLE 292 ROKIT HEALTHCARE, INC.: BUSINESS OVERVIEW
12.1.11 REGENOVO BIOTECHNOLOGY CO., LTD. (PART OF SHINING 3D TECH CO., LTD.)
TABLE 293 REGENOVO BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.1.12 PANDORUM TECHNOLOGIES PVT. LTD.
TABLE 294 PANDORUM TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW
12.1.13 FOLDINK LIFE SCIENCE TECHNOLOGIES
TABLE 295 FOLDINK LIFE SCIENCE TECHNOLOGIES: BUSINESS OVERVIEW
12.1.14 REVOTEK CO., LTD.
TABLE 296 REVOTEK CO., LTD.: BUSINESS OVERVIEW
12.1.15 PRECISE BIO
TABLE 297 PRECISE BIO: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 BRINTER
12.2.2 PRELLIS BIOLOGICS
12.2.3 REGEMAT 3D
12.2.4 3DBIO THERAPEUTICS
12.2.5 TISSUE REGENERATION SYSTEMS INC.
12.2.6 POIETIS
12.2.7 SUNP BIOTECH, LLC
12.2.8 VIVAX BIO, LLC
12.2.9 GESIM MBH
12.2.10 MANCHESTER BIOGEL
*Details on Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX (Page No. – 262)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATION
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
